Single-agent docetaxel (TXT) as first-line treatment in metastatic breast cancer (MBC)

被引：0
|
作者：
Guarneri, D. [1 ]
Ratti, R. [1 ]
Venturino, A. [1 ]
Addamo, G. [1 ]
Coccorullo, Z. [1 ]
Colloca, G. [1 ]
Campora, E. [1 ]
机构：
[1] Hosp Sanremo, San Remo, IM, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11515
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Single-agent paclitaxel as first-line treatment of metastatic breast cancer: The British experience
    Davidson, NG
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 6 - 10
  • [2] Biweekly docetaxel (T) and capecitabine (X) as first-line treatment of metastatic breast cancer (MBC).
    Adrover, E
    Mayordomo, JI
    Llorca, C
    Burillo, MA
    Sanz, J
    Madroñal, C
    Lorenzo, A
    Palombo, H
    Janartz, J
    Pujol, E
    Machengs, I
    Yubero, A
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S202 - S202
  • [3] SINGLE-AGENT CAPECITABINE AS FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2009, 15 (01): : 46 - 49
  • [4] First-line, single-agent Herceptin® (trastuzumab) in metastatic breast cancer:: a preliminary report
    Vogel, C
    Cobleigh, MA
    Tripathy, D
    Gutheil, JC
    Harris, LN
    Fehrenbacher, L
    Slamon, DJ
    Murphy, M
    Novotny, WF
    Burchmore, M
    Shak, S
    Stewart, SJ
    EUROPEAN JOURNAL OF CANCER, 2001, 37 : S25 - S29
  • [5] WEEKLY DOCETAXEL (WEDO) AS FIRST-LINE THERAPY IN ELDERLY METASTATIC BREAST CANCER (MBC)
    Caristi, Nicola
    Maisano, Roberto
    Mare, Marzia
    Chiofalo, Giuseppe
    Picciotto, Maria
    Mafodda, Antonio
    Montalto, Erika
    Zavettieri, Maria
    La Torre, Francesco
    ANNALS OF ONCOLOGY, 2004, 15 : 19 - 20
  • [6] Capecitabine (X) in the first-line treatment of metastatic breast cancer (MBC).
    Harbeck, N.
    Kaufmann, M.
    Siedentopf, F.
    Dalivoust, P.
    Debled, M.
    Robert, N. J.
    O'Shaughnessy, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Comparative efficacy and acceptability of first-line single-agent chemotherapy in metastatic breast cancer.
    Wang, Ying
    Yu, Yunfang
    Ou, Qiyun
    Gao, Quanlong
    Fu, Tuping
    Lin, Dagui
    Yao, Herui
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer
    Kamal, A. H.
    Camacho, F.
    Anderson, R.
    Wei, W.
    Balkrishnan, R.
    Kimmick, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 371 - 378
  • [9] Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer
    A. H. Kamal
    F. Camacho
    R. Anderson
    W. Wei
    R. Balkrishnan
    G. Kimmick
    Breast Cancer Research and Treatment, 2012, 134 : 371 - 378
  • [10] Low dose sequential docetaxel-capecitabine chemotherapy as first-line treatment of metastatic breast cancer (mbc)
    Hafeez, M.
    Shaharyar, A.
    Masood, A. I.
    Zikria, M.
    Usman, A.
    Shabbir, K.
    Nadeem, Z.
    Tahir, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345